Induction of the ChREBPβ Isoform Is Essential for Glucose-Stimulated β-Cell Proliferation. Academic Article uri icon

Overview

abstract

  • Carbohydrate-responsive element-binding protein (ChREBP) is a glucose-sensing transcription factor required for glucose-stimulated proliferation of pancreatic β-cells in rodents and humans. The full-length isoform (ChREBPα) has a low glucose inhibitory domain (LID) that restrains the transactivation domain when glucose catabolism is minimal. A novel isoform of ChREBP (ChREBPβ) was recently described that lacks the LID domain and is therefore constitutively and more potently active. ChREBPβ has not been described in β-cells nor has its role in glucose-stimulated proliferation been determined. We found that ChREBPβ is highly expressed in response to glucose, particularly with prolonged culture in hyperglycemic conditions. In addition, small interfering RNAs that knocked down ChREBPβ transcripts without affecting ChREBPα expression or activity decreased glucose-stimulated expression of carbohydrate response element-containing genes and glucose-stimulated proliferation in INS-1 cells and in isolated rat islets. Quantitative chromatin immunoprecipitation, electrophoretic mobility shift assays, and luciferase reporter assays were used to demonstrate that ChREBP binds to a newly identified powerful carbohydrate response element in β-cells and hepatocytes, distinct from that in differentiated 3T3-L1 adipocytes. We conclude that ChREBPβ contributes to glucose-stimulated gene expression and proliferation in β-cells, with recruitment of ChREBPα to tissue-specific elements of the ChREBPβ isoform promoter.

publication date

  • September 17, 2015

Research

keywords

  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
  • Hyperglycemia
  • Insulin-Secreting Cells
  • Nuclear Proteins
  • Transcription Factors
  • Up-Regulation

Identity

PubMed Central ID

  • PMC4657577

Scopus Document Identifier

  • 84962172851

Digital Object Identifier (DOI)

  • 10.2337/db15-0239

PubMed ID

  • 26384380

Additional Document Info

volume

  • 64

issue

  • 12